ENTITY
Abbott India

Abbott India (BOOT IN)

66
Analysis
Health Care • India
Abbott India Limited is a publicly listed subsidiary of Abbott Laboratories, operating as a significant pharmaceutical company in India. It develops, manufactures, and markets science-based healthcare products across various therapeutic areas, including women's health, gastroenterology, metabolics, central nervous system, and vaccines. The company was incorporated on August 22, 1944, and is headquartered in Mumbai, Maharashtra, India.
more
bullish•Mankind Pharma
•08 Feb 2023 09:48

Mankind Pharma Pre-IPO - Peer Comparison - One of the Largest, with Better Growth and Margins

Mankind Pharma is looking to raise about US$1bn in its upcoming India IPO. In this note, we will undertake a peer comparison.

Logo
669 Views
Share
bullish•Pi Industries
•24 Aug 2021 19:23

NIFTY NEXT50 Index Rebalance: More Beneath The Surface

There are 5 changes to the NIFTY Next 50 Index that will be implemented at the close on 29 September. The impact is quite large compared to the...

Logo
520 Views
Share
bullish•Abbott India
•12 Jul 2021 08:26

Global Equity Strategy: Mixed Market Environment Continues As Yields Break Down

The Hang Seng, EURO STOXX 50, MSCI ACWI ex-US, and MSCI EAFE display bearish short-term inflections and 10-year yields in the US and Germany are...

Logo
360 Views
Share
•27 May 2021 09:12

India: Stock Reclassification & Active Portfolio Management

There are a lot of segment changes expected in July when AMFI recategorizes stocks and mutual funds start to rebalance their portfolios. We...

Logo
548 Views
Share
bullish•SBI Card
•02 Jul 2020 09:58

India Stock Classification Changes - Active Portfolio Churn

Once up a time in India, there was a smorgasbord of mutual fund schemes launched by different fund houses. The same fund house had myriad schemes...

Logo
734 Views
Share
x